The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Breast cancer is the most prevalent cancer in women worldwide. About 15-20% of all breast cancers do not express estrogen receptor, progesterone receptor or HER2 receptor and hence are collectively classified as triple negative breast cancer (TNBC). These tumors are often relatively aggressive when...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Wu, Xinyan, Saddiq, Muhammad Zahari, Renuse, Santosh, Kelkar, Dhanashree S, Barbhuiya, Mustafa A, Rojas, Pamela L, Stearns, Vered, Gabrielson, Edward, Malla, Pavani, Sukumar, Saraswati, Mahajan, Nupam P, Pandey, Akhilesh
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356856/
https://ncbi.nlm.nih.gov/pubmed/27902967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13579
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados